Pharmaceutical formulation comprising a coated tablet
EP4757782A1Pending Publication Date: 2026-06-17F HOFFMANN LA ROCHE & CO AG +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- EP2024755252
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-08-11
- Filing Date
- 2024-08-09
- Publication Date
- 2026-06-17
AI Technical Summary
Technical Problem
Current formulations of GDC-0077 (INAVOLISIB) lack stability, particularly against light degradation, which affects its efficacy and longevity.
Method used
A pharmaceutical formulation comprising a therapeutically effective amount of GDC-0077 (INAVOLISIB) in a solid dosage form with a colored coating, which provides improved light stability and protection against physical and chemical degradation.
Benefits of technology
The formulation enhances the light stability of GDC-0077 (INAVOLISIB), minimizing degradation and maintaining the active ingredient's potency, while also improving manufacturability and reducing costs.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure EP2024072652_20022025_PF_FP_ABST
Abstract
The invention relates to pharmaceutical formulation in form of a pharmaceutical formulation comprising GDC-0077 (INAVOLISIB) or a salt thereof, the formulation having a colored coating.
Need to check novelty before this filing date? Find Prior Art